跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 14 条关于
“DAYBREAK”
全部
14
临床试验
5
药物
0
机构
0
资讯
9
去年
Kodiak Sciences Completes Enrollment in GLOW2 Phase 3 Trial for Diabetic Retinopathy Treatment
去年
Kodiak Sciences' Tarcocimab Shows Promise in Phase 3 Retinal Disease Trials, Analyst Upgrades Stock
3个月前
Bexobrutideg Shows High Response Rates and Manageable Safety in BTK Degrader Trial for Relapsed/Refractory CLL
去年
Rhythm Pharmaceuticals Reports Strong Q3 2024 Driven by IMCIVREE Sales, Advances Hypothalamic Obesity Program
去年
Ozanimod Shows Sustained Reduction in Brain Atrophy in Relapsing Multiple Sclerosis
去年
Breakthrough Year in Multiple Sclerosis Research: Key Advances and Treatment Milestones in 2024
去年
First Nations Launch Comparative Drug Trial to Combat Psoroptic Mange in Declining Bighorn Sheep Population
5个月前
Kodiak Sciences' Zenkuda Achieves 62.5% Response Rate in Phase 3 GLOW2 Diabetic Retinopathy Trial
上个月
Kodiak Sciences Completes Enrollment in First Pivotal Cohort of Phase 3 PEAK Trial for KSI-101 in Macular Edema Secondary to Inflammation